<DOC>
	<DOC>NCT02511912</DOC>
	<brief_summary>This is a prospective, non-randomized, open label, single-arm multi-center study.</brief_summary>
	<brief_title>REducing Lung Congestion Symptoms Using thE V-wavE Shunt in Advanced Heart Failure</brief_title>
	<detailed_description>This is a prospective, non-randomized, open label, single-arm multi-center study evaluating the perfromance and safety of the V-Wave interatrial shunt when implanted in chronic heart failure patients with both reduced and preserved ejection fraction.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1. Chronic (&gt;6 months) ischemic or nonischemic cardiomyopathy, ACC/AHA Stage C, NYHA Class III or ambulatory Class IV heart failure, Receiving optimal guideline directed medical therapy as defined by ACC/AHA guidelines 2. Patient or legally acceptable representative, signed a written informed consent form (ICF) to participate in the study 3. Ejection Fraction â‰¥ 15% 1. Right Heart Failure 2. Right Atrial Pressure (RAP) &gt; Left Atrial Pressure (LAP) 3. Congenital heart disease 4. Severe pulmonary hypertension 5. Severe restrictive or obstructive lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>